Mice treated with CBT-511 had a significant reduction in tumor size compared to those given mock CAR-T treatments (mean tumor volume of mock CAR-T versus DCLK1 CAR-T = 2123 versus 1216 mm3 with a p = 0.02; Figure 5B). Here, DCLK1 is linked to neoplasm.